AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

NCT07454642 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Vulvar Adenocarcinoma
PDAC - Pancreatic Ductal Adenocarcinoma
Gastric Adenocarcinoma
GEJ Adenocarcinoma
Cervical Adenocarcinoma
Cervical Adenosquamous Carcinoma
Small Cell Carcinoma of Lung

Interventions

DRUG: AVA6103

Sponsor

Avacta Life Sciences Ltd